webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate

  CAS No.:   Cat No.: BADC-00425   Purity: 98% 4.5  

2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate is a pharmaceutical compound widely used in the biomedical field. Its powerful medicinal properties are effective against drug-resistant strains, especially in overcoming Gram-positive infections.

2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C21H30N2O8
Molecular Weight
438.47
Shipping
Room temperature
Shipping
-20°C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Cyclooctyne-PEG2-Osu; Cyclooctyne-PEG2-NHS ester
Appearance
Soild powder
Shipping
Room temperature
Storage
-20°C

The first key application of 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate is in the field of bioconjugation. This compound can be used to create a stable linkage between various bio-molecules such as proteins, antibodies, peptides, and other biological entities. The reactive N-hydroxysuccinimide (NHS) ester group is a critical functional element allowing it to efficiently conjugate with primary amines found in proteins and peptides. This makes it a versatile tool in generating bioconjugates for use in diagnostics, therapeutics, and research applications. Through successful bioconjugation, scientists can develop more effective enzyme-linked immunosorbent assays (ELISAs), antibody-drug conjugates (ADCs), and multi-functional biomolecules for targeted drug delivery and precise diagnostic tools.

Another significant application of this compound is in drug delivery systems. The presence of the cyclooctynyl moiety in its structure allows it to be used in click chemistry reactions, specifically strain-promoted alkyne-azide cycloaddition (SPAAC). This reaction enables rapid, biocompatible covalent bonding under mild conditions, making it suitable for use in vivo. By utilizing the click chemistry approach, 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate can be used to develop advanced drug delivery vehicles. These vehicles can be functionalized with targeting ligands or therapeutic agents, providing controlled and site-specific release of drugs. This leads to enhanced efficacy and reduced side effects, improving the overall outcomes in treatments of diseases like cancer, infectious diseases, and chronic conditions.

The third application of this compound lies in the development of advanced biomaterials. With the increasing need for materials that can mimic the properties of natural tissues, 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate can be employed in the synthesis of functionalized polymers and hydrogels. These materials can be engineered to present specific biological signals, enhancing cell adhesion, proliferation, and differentiation. In tissue engineering and regenerative medicine, this enables the creation of scaffolds that support the growth and integration of new tissues, facilitating the repair and regeneration of damaged tissues. The ability to conjugate this compound with different bioactive molecules allows for the customization of biomaterials for various applications, including wound healing, artificial organs, and biomedical implants.

Lastly, this compound has applications in bioorthogonal chemistry, which involves chemical reactions that can occur inside living organisms without interfering with native biochemical processes. This unique property makes 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate valuable for in vivo labeling and imaging. By tagging biomolecules with this compound, researchers can track and visualize cellular processes in real-time, providing insights into cellular signaling, protein interactions, and metabolic pathways. The high specificity and biocompatibility of bioorthogonal reactions ensure minimal disruption to the organism while yielding accurate and dynamic biological data. This application is particularly valuable in the fields of developmental biology, neuroscience, and cancer research, where understanding intricate biological systems is crucial.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 2,5-dioxopyrrolidin-1-yl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate | 4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene | Amino-PEG4-Val-Cit-PAB-MMAE | MC-PEG2-C2-NHS ester | Poc-Cystamine hydrochloride | Boc-Val-Ala-PAB-PNP | BCN-PEG1-Val-Cit-OH | Aminooxy-PEG2-BCN | Biotin-PEG2-acid | Fmoc-Gly-Gly-Phe-OH | 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate
Send Inquiry
Verification code
Inquiry Basket